fluticasone furoate-vilanterol Breo
Selected indexed studies
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. (N Engl J Med, 2018) [PMID:29668352]
- ** (, 2016) [PMID:28121097]
- Fluticasone furoate/vilanterol: a review of its use in patients with asthma. (Drugs, 2015) [PMID:25648266]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD. (2018) pubmed
- PMID:28121097 (2016) pubmed
- Pharmaceutical Approval Update. (2015) pubmed
- Fluticasone furoate/vilanterol: a review of its use in patients with asthma. (2015) pubmed
- Fluticasone furoate/vilanterol: a review of its use in chronic obstructive pulmonary disease. (2014) pubmed
- Effect of fluticasone propionate/formoterol and fluticasone furoate/vilanterol on adolescents with chronic bronchial obstruction. (2024) pubmed
- Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. (2019) pubmed
- Once-daily fluticasone furoate/vilanterol vs once-daily fluticasone furoate in patients with asthma aged 5 to 17 years. (2024) pubmed
- Once-daily fluticasone furoate and vilanterol for adolescents and adults with symptomatic asthma: A systematic review with meta-analysis. (2016) pubmed
- Fluticasone Furoate/Vilanterol Use Trends and Characteristics in Patients With Obstructive Airway Disease: A Real-World Study of 10,374 Patients From India. (2023) pubmed